SCHEMBL8217909

SCHEMBL8217909

CC(C)N1CC2(CCN(C(=O)Nc3ccccc3)CC2)C1c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CACNA1H O95180 8/20 0.69
TRPV1 Q8NER1 5/20 0.53
TSHR P16473 1/20 0.50
CYP2C19 P33261 1/20 0.50
ALDH1A1 P00352 2/20 0.49
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
NPC1 O15118 1/20 0.46
TP53 P04637 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 1/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8225905 0.92 CACNA1H (0.78) CACNA1HTRPV1
SCHEMBL8224175 0.89 CACNA1H (0.86) CACNA1HTRPV1CYP2C19ALDH1A1CYP1A2
SCHEMBL8226349 0.88 CACNA1H (0.84) CACNA1HTRPV1NPC1
SCHEMBL8228087 0.87 CACNA1H (0.58) CACNA1HTRPV1SMN1; SMN2
SCHEMBL13595875 0.86 CACNA1H (0.83) CACNA1HTRPV1
SCHEMBL8226558 0.86 CACNA1H (0.72) CACNA1HTRPV1NPC1TP53RAB9A
SCHEMBL8229860 0.85 CACNA1H (0.56) CACNA1HTRPV1CYP2C19ALDH1A1CYP1A2
SCHEMBL8224751 0.84 CACNA1H (0.84) CACNA1HTRPV1ALDH1A1CYP2D6NPC1
SCHEMBL13595868 0.83 CACNA1H (0.78) CACNA1HTSHRALDH1A1NPC1RAB9A
SCHEMBL8227800 0.83 CACNA1H (0.64) CACNA1HTRPV1ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008033460-A2 TREATING PAIN, DIABETES, AND LIPID METABOLISM DISORDERS SCHERING CORPORATION (US) 2008-03-20 WO disclosed